OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 76 citing articles:

Necroptosis inhibitors: mechanisms of action and therapeutic potential
Yingbo Zhou, Zhangtao Cai, Yijia Zhai, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 22-44
Closed Access | Times Cited: 15

PROTACs Targeting MLKL Protect Cells from Necroptosis
Oliver H. Rathje, Lara Perryman, Richard J. Payne, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11216-11236
Closed Access | Times Cited: 13

Lung-derived HMGB1 is detrimental for vascular remodeling of metabolically imbalanced arterial macrophages
Ludovic Boytard, Tarik Hadi, Michele Silvestro, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 39

Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases
Pedro A. Dionísio, Joana D. Amaral, Cecília M. P. Rodrigues
International review of cell and molecular biology (2020), pp. 31-82
Closed Access | Times Cited: 38

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
Elise DeRoo, Ting Zhou, Bo Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8174-8174
Open Access | Times Cited: 36

Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
Kunyu Shi, Jifa Zhang, Enda Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 14971-14999
Closed Access | Times Cited: 21

Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma
Xiaofei Liu, Jintao Zhang, Dong Zhang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4

MLKL activity requires a splicing-regulated, druggable intramolecular interaction
Uris Ros, Veronica Martinez-Osorio, Pedro A. Valiente, et al.
Molecular Cell (2025)
Open Access

Necroptosis: a significant and promising target for intervention of cardiovascular disease
Yanwei Ji, Xinyu Wen, He-peng Tang, et al.
Biochemical Pharmacology (2025), pp. 116951-116951
Closed Access

Macrophage Biology in Cardiovascular Diseases
Mitri K. Khoury, Huan Yang, Bo Liu
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 41, Iss. 2
Open Access | Times Cited: 31

Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model
Masoomeh Sharifi, Donya Nazarinia, Fatemeh Ramezani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 3, pp. 2507-2518
Closed Access | Times Cited: 25

No Time to Die: How Kidney Cancer Evades Cell Death
Carlo Ganini, Manuela Montanaro, Manuel Scimeca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6198-6198
Open Access | Times Cited: 17

Endothelial RIPK1 protects artery bypass graft against arteriosclerosis by regulating SMC growth
Yao Lu, Yiming Leng, Yalan Li, et al.
Science Advances (2023) Vol. 9, Iss. 35
Open Access | Times Cited: 9

HMGB1/TLR4 signaling pathway enhances abdominal aortic aneurysm progression in mice by upregulating necroptosis
Shuai Bian, Le Yang, Dongfang Zhao, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 703-713
Closed Access | Times Cited: 8

Thrombosis in the pathogenesis of abdominal aortic aneurysm
Jack Bontekoe, Jon S. Matsumura, Bo Liu
JVS Vascular Science (2023) Vol. 4, pp. 100106-100106
Open Access | Times Cited: 8

Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
Lijuan Xu, Chunlin Zhuang
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1974-2024
Closed Access | Times Cited: 8

Design, synthesis, molecular docking and biological evaluation of 1,3,5-trisubstituted-1H-pyrazole derivatives as anticancer agents with cell cycle arrest, ERK and RIPK3- kinase activities
Nader M. Boshta, Ahmed Temirak, Zeinab A. Elshahid, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107058-107058
Closed Access | Times Cited: 8

RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling
Na He, Yu‐Juan Qu, Danyang Li, et al.
Aging (2021) Vol. 13, Iss. 21, pp. 24417-24431
Open Access | Times Cited: 19

MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis
Ting Zhou, Elise DeRoo, Huan Yang, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2397-2397
Open Access | Times Cited: 17

MicroRNA-513b-5p targets COL1A1 and COL1A2 associated with the formation and rupture of intracranial aneurysm
Zheng Zheng, Yan Chen, Yinzhou Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16

Stretchable Encapsulation Materials with High Dynamic Water Resistivity and Tissue-Matching Elasticity
Yan Shao, Shancheng Yan, Jun Li, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 16, pp. 18935-18943
Open Access | Times Cited: 12

A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype
Junmin Fu, Yingda Zang, Yu Zhou, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 126, pp. 110084-110084
Open Access | Times Cited: 16

Screening of potent RIPK3 inhibitors to attenuate necroptosis and inflammation in mouse traumatic brain injury models
Xue Sun, Yu Wu, Feng Xu, et al.
Experimental Neurology (2023) Vol. 372, pp. 114633-114633
Closed Access | Times Cited: 6

Scroll to top